Interaction between tramadol and two anti-emetics on nociception and gastrointestinal transit in mice

Christian Dürsteler1, Anna Mases, Victor Fernandez

  • 1Department of Anaesthesiology, Hospital Universitario del Mar, Universidad Autónoma de Barcelona, Paseo Marítimo 25, 08003 Barcelona, Spain.

Abstract

Insights

This study found that tramadol and anti-emetics like ondansetron and droperidol have an antagonistic interaction on pain relief and gastrointestinal transit in mice. This interaction varies depending on the pain stimulus, supporting previous clinical findings.

Area of Science:

  • Pharmacology
  • Pain Management
  • Gastrointestinal Physiology

Background:

  • Clinical evidence suggests ondansetron partially antagonizes tramadol-induced analgesia.
  • Understanding drug interactions is crucial for optimizing therapeutic outcomes and patient safety.

Purpose of the Study:

  • To investigate the interaction between tramadol and two anti-emetics (ondansetron and droperidol) on antinociception and gastrointestinal transit in mice.
  • To determine the nature of these interactions (e.g., additive, synergistic, antagonistic).

Main Methods:

  • Utilized acetic acid writhing and plantar tests to assess antinociceptive effects in female Swiss CD-1 mice.
  • Evaluated antitransit effects using a charcoal meal assay.
  • Employed isobolographic analysis and ANOVA to characterize drug interactions.

Main Results:

  • Both tramadol-ondansetron and tramadol-droperidol combinations showed antagonism in the writhing test.
  • Tramadol-ondansetron demonstrated antagonism in the plantar test, while tramadol-droperidol showed no significant interaction.
  • Both anti-emetics antagonized the gastrointestinal transit inhibitory effects of tramadol.

Conclusions:

  • The interaction between tramadol and anti-emetics on antinociception is stimulus-dependent, exhibiting antagonism or additive effects.
  • Both ondansetron and droperidol antagonize the anti-transit effects of tramadol.
  • These findings support previous clinical observations of antagonism between tramadol and these anti-emetics.

Related Concept Videos

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...